GSK secures first lung cancer approval, validating $10.6bn Nuvalent bet
Jideytro will now enter a lung cancer niche dominated by Pfizer’s Lorbrena.
Jideytro will now enter a lung cancer niche dominated by Pfizer’s Lorbrena.
BMS enhances its AI computing power as big pharma race to stay competitive within the shifting global landscape.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Turning AI skeptics into AI advocates through high-integrity data
Keeping pace with generative AI in pharmaceutical and healthcare organisations
Pharma Meets AI Conference 2026: Key barriers to scaling AI in drug development
Advancing pressure protection in biopharma: how integrated bypass technology elevates single-use pump design